📊 Backtest📒 Journal Updated 29/09/2026
← 🔥 Turbo
📐 Simulate Position
STALE?Report written 13 days ago · at $7.65entry levels may be stale — re-check before acting

CRML

Moonshot
Critical Metals Corp. · NASDAQ · Materials / Rare Earth & Critical Minerals Mining
$7.65
▼ 2.30%
MCap ~$1.12B
Close of $7.65 on Sep 28, 2026 (-2.3%). The Aug 11 report priced this at $6.38; the stock then ran to a $9.33 peak on Sep 21 (+46% cumulative) as a Sep 15 court ruling cleared the path to the Oct 22 EGM and a Sep 16 Tanbreez refinery yield breakthrough landed — then gave back ~18% into month-end profit-taking. Net +20% since the last report. 52-week range now $5.12-$32.15.
BusinessRare earth + lithium developer · 92.5% owner of Tanbreez (Greenland, one of the largest known heavy-REE resources globally) + Wolfsberg Lithium (Austria, BMW offtake) + Romania refinery JV with Nuclearelectrica (NATO/EU defense-magnet supply chain) · pending all-share acquisition of European Lithium — court-ordered Scheme Meetings set for Oct 22, 2026 · finalist in Kenya's Mrima Hill rare-earth/niobium government tender
Thesis

The catalyst that anchored the Aug report — a 'late August' EGM — actually landed as a hard, court-ordered date: European Lithium's Scheme Meetings are now set for Oct 22, 2026 (Scheme Booklet dispatched ~Sep 22, court approval granted Sep 15), with implementation targeted November 2026 and a Nasdaq listing for the combined entity expected ~Nov 6. The deal mechanics also changed materially: the fixed 0.035 exchange ratio became a floating 0.025-0.045 cap/collar band, and EuLi holders will own ~41% of the combined company — real, mechanical dilution independent of the previously-flagged A$36.5-37M EuLi cash shortfall, whose resolution status hasn't resurfaced in recent coverage and is therefore unconfirmed, not verified closed. Unusually, the market broke its own 'sell CRML's good news' pattern this cycle: shares ran +46% from the Aug 11 report price into a Sep 21 peak on the court-clearance + a Sep 16 Tanbreez refinery breakthrough (99% dissolution of eudialyte concentrate into 19 ultra-high-purity REE products, implying $1.8-2.2B in potential annual refinery revenue), before giving back ~18% into Sep 28 on profit-taking. Kenya's Mrima Hill tender remains unresolved — still 1 of 3 finalists, no award date. Survival check clears: cash stood at $102.5M as of Jun 30, 2026 (up from $7.3M a year earlier via 2025 PIPE financings), against negative working capital of ~-$15.4M and positive equity of $368M — no active shelf/ATM identified, so this is a dilution-and-execution story, not a near-term financing-risk one. Thesis intact but re-anchored: the Oct 22 EGM is now the clean, dated binary this report is built around.

📝 Primary Verdict · Core Holding
SPECULATIVEMoonshot

Moonshot — the Oct 22 EGM is now a hard, court-ordered date (regulatory_approval catalystType is a lane leader at +5.3pp median excess vs +2.0pp overall, n=8), and the market broke its own 'sell the good news' pattern this cycle, running the stock +46% into the Sep 21 peak on court clearance + a Tanbreez refinery breakthrough. But turbo's own entry-timing data shows -13.7% median drawdown from report price to catalyst (n=19, 79% negative) — so Entry 1 here is NOT preferred; size small and prefer the Entry 2 dip zone. Stops widened to -28%/-45% to clear the regulatory_approval bucket's own -25% median MAE.

88
score / 100 ⓘ
⚡ Catalyst
🗳️ European Lithium Scheme Meetings / EGM Vote — Oct 22, 2026~3 WEEKS

Court-ordered general meeting and Scheme Meetings for European Lithium security-holders, in West Leederville, Western Australia. Requires shareholder approval of the scheme resolutions (Scheme Booklet dispatched ~Sep 22, 2026) plus subsequent Australian court confirmation. The exchange ratio is now a floating 0.025-0.045 cap/collar band (vs the original fixed 0.035), and EuLi holders will own ~41% of the combined company post-close. The previously-disclosed ~A$36.5-37M EuLi minimum-cash shortfall has not resurfaced in recent coverage — its resolution is unconfirmed, not verified closed.

Oct 22, 2026
🔀 Merger Implementation + Nasdaq Listing (if approved)~5-6 WEEKS (IF APPROVED)

If the Oct 22 vote and subsequent court confirmation succeed, implementation is targeted for November 2026 — ASX delisting of European Lithium ~Oct 27, 2026, Nasdaq listing of the combined entity ~Nov 6, 2026.

~Nov 6, 2026
⛏️ Kenya Mrima Hill Rare Earth/Niobium Tender — Final RoundFINAL ROUND — DECISION PENDING

The Mrima Earth Limited Consortium, led by Critical Metals, remains one of three finalists in Kenya's government tender for the Mrima Hill rare-earth + niobium project. No award date disclosed as of late Sep 2026.

H2 2026
🏗️ Tanbreez Refinery Scale-Up (Romania JV)ONGOING

Sep 16, 2026 metallurgical results showed 99% dissolution of eudialyte concentrate into 19 ultra-high-purity rare-earth products, with projected annual refinery revenue of $1.8-2.2B if scaled — an ongoing de-risking process, not a single dated event.

Ongoing
🎯 Entry Point
Entry 1
$7.65
Current — small only. Turbo's own entry-timing data shows the median position is down -13.7% by the time a name reaches its catalyst (n=19, 79% of windows negative at that point), so this level is not the preferred entryNow (small)
Entry 2PREFERRED
$6.2–6.6
Pullback zone matching the turbo lane's -13.7% median entry-to-catalyst drawdown — better R/R ahead of the Oct 22 EGMIf dips
Entry 3
$5.12
Near the 52-week low — verify no fresh dilutive filing or EGM setback news firstDeep dip (verify news first)
✅ Take Profit
TP1
Base — Oct 22 EGM approves on schedule, Nov implementation proceeds, Kenya tender still pending
$9.95
+30%
TP2
Bull — merger implements cleanly + Kenya tender win + Tanbreez refinery economics get priced in
$15.3
+100%
TP3 🌙
Moon — full sector re-rate, stock revisits its own 52-week high
$32.15
+320%
🔴 Stop Loss
Tight Stop
Below Entry 2 zone — set wider than the regulatory_approval catalystType's own -25% median MAE (n=8) per the feedback prior, not thesis pessimism
$5.51
-28%
Hard Stop
Below 52-week low support — thesis-level breach (EGM fails, Kenya lost, or fresh dilutive raise)
$4.21
-45%
Risk / Reward
vs TP2, using the wider MAE-compliant tight stop — lower than the prior report's 8.4:1 because the stop had to widen, not because the setup weakened
3.6 : 1
⚠ Moonshot — real merger-driven dilution (EuLi at ~41% of combined co, floating 0.025-0.045 ratio) plus the unresolved cash-gap disclosure status. Size ≤3% of portfolio.
📅 Estimate Date
European Lithium Scheme Meetings / EGM Vote
Dual-majority vote required; EuLi cash-gap resolution status unconfirmed in recent coverage
Oct 22, 2026
Binary: approved / delayed / falls through
Merger Implementation + Nasdaq Listing
Targeted if Oct 22 vote + court confirmation succeed; ASX delisting ~Oct 27, 2026
~Nov 6, 2026
Conditional on Oct 22 approval
Kenya Mrima Hill Tender Outcome
Still 1 of 3 finalists; no award date disclosed
H2 2026 (timing TBD)
Binary: win / lose tender
Tanbreez Refinery Scale-Up
Sep 16, 2026: 99% dissolution yield into 19 ultra-high-purity REE products confirmed at test scale
Ongoing
De-risking process, no single date
📈 Possible Up % — Scenario Spread
Bear
-45%
$4.21
Base
+30%
$9.95
Bull
+100%
$15.3
Moon
+320%
$32.15
← downsideupside →
🏛️ Fed / Macro Risk — LOW

Assesses how Fed policy / interest rates / inflation affect this stock — LOW = minimal risk, HIGH = proceed with caution

Rate Outlook
Last confirmed Fed action: held at 3.50-3.75% on Jul 29, 2026 with 3 hawkish dissents; weak Jul NFP (-23K) had pulled hike odds down since. CRML's thesis remains resource/geopolitics-driven (Western critical-minerals sourcing policy, Greenland/Kenya project execution), largely decoupled from the rate cycle.
Inflation
Core PCE was running 3.3% YoY as of the last confirmed read, above the 2% target — doesn't change the rare-earth supply-security narrative driving this stock.
Sector Impact
MEDIUM-HIGH. A pre-revenue, high-beta resource developer with an active merger-driven dilution path is more exposed than most to a risk-off tape that makes further capital-markets access more expensive.
Summary
Fed risk LOW on the core thesis (geopolitics/policy-driven, not rate-driven) — CRML's own catalyst calendar (Oct 22 EGM, Nov implementation, Kenya tender outcome) dominates the stock's direction far more than macro does.
🎯 Analyst Targets

Wall Street price targets vs the current price — cross-check our TP levels

Consensus (12-mo avg)
Buy$13+70%
Cantor Fitzgerald
Buy$18+135%
current price $7.65
🔍 Similar-Catalyst Comparable Check

Stocks that went through similar catalyst events — calibrate whether the +30%+ target is realistic

CRML✅ GoodSep 2026
+46%
in 41 days
Court approval clears path to Oct 22 EGM + Tanbreez refinery yield breakthrough
First time in 2026 the market priced in anticipated good news ahead of a dated event rather than fading it same-day — ran from the Aug 11 report price to a Sep 21 peak before giving back ~18% into month-end profit-taking.
CRML✅ GoodAug 2026
+16.2%
in 1 day
Sector-wide Western rare-earth policy sentiment pop — no company news
Cleanest 'pure sentiment' precedent — reflects sector beta/policy sentiment more than CRML-specific execution.
CRML❌ BadMay 2026
-5.99%
in 1 day
Binding European Lithium acquisition agreement signed
Market sold a genuinely balance-sheet-accretive deal same-day, pricing in dilution — the pattern the Sep 15-21 rally broke for the first time.
CRML❌ BadJul 2026
-6.29%
in 1 day
Kenya Mrima Hill tender advances to final round
Same pattern repeated on a second independent positive catalyst — reinforces that dilution/execution-risk fear, not catalyst outcome, was the dominant near-term driver until the Sep 2026 rally.
⚡ Optional Layer · Tactical Overlay
🎯 Catalyst Spot Mode

Short-term play around the catalyst (Sep 2026 earnings) only — an optional overlay, not a verdict that ranks equal to the Core Holding.

⚠️

Use this stop-loss set (-28% / -20%) only when trading the earnings spot — not for the core holding (use the -28% / -45% set above). If you are holding long-term, follow the core set.

📈Pre-Catalyst Run-up Pattern
+46% cumulative into the Sep 21 peak; net +20% held as of Sep 28 after giving back ~18%~5-6 weeks of anticipatory drift this cycle (Aug 11 report to Sep 21 peak) — a change from the prior 'no drift, same-day-only' pattern

This report period broke CRML's earlier 'sell the news' pattern: the stock rallied continuously from the Aug 11 report price of $6.38 to a Sep 21 peak of $9.33 (+46% cumulative), coinciding with the Sep 15 court ruling clearing the path to the Oct 22 EGM and the Sep 16 Tanbreez refinery yield breakthrough — evidence the market anticipated the court clearance and processing validation rather than only reacting same-day, as it had all year. Since the Sep 21 peak, shares have given back ~18% into the Sep 28 close on profit-taking.

🎲Historical Post-Catalyst Move
✅ Catalyst Winavg +25%
range: +16% to +46%· Aug 3, 2026 & Sep 15-21, 2026
Blends two real 2026 events: the Aug 3 sector-wide same-day pop (+16.2%, zero company news) and the Sep 15-21 multi-week court-approval + refinery-validation rally (+46% cumulative before giving back gains) — the latter is the first time CRML's own event-driven news produced a sustained rally rather than a same-day fade.
❌ Catalyst Missavg -10%
range: -6% to -18%· May 18, 2026, Jul 23, 2026 & Sep 21-28, 2026
Two distinct downside patterns: CRML's own genuinely positive news has twice triggered same-day selling (-5.99% on the binding EuLi agreement, May 18; -6.29% on the Kenya tender advancing, Jul 23), while the Sep 21-28 pullback (-18%) was profit-taking after a run rather than a reaction to bad news — a different, less alarming mechanism worth distinguishing ahead of the Oct 22 EGM.
💼Spot Position Sizing
How the recommended % is derived
3%
of portfolio

Moonshot sizing — regulatory_approval catalystType is a lane leader (+5.3pp median excess vs +2.0pp overall, n=8 completed windows), a real tailwind, but real merger-mechanics dilution (EuLi at ~41% of combined co, floating 0.025-0.045 exchange ratio) plus the unresolved cash-gap disclosure status argue against sizing above the 3% floor.

🛑Stop Loss · Spot Trade
Spot cut-loss levels — separate from the core holding
Before Catalyst
-28%($5.51)
Below Entry 2 zone before the Oct 22 EGM = market pricing in vote failure, an unresolved cash gap, or a fresh dilutive filing. Set wider than the regulatory_approval bucket's own -25% median MAE per the feedback prior.
After Catalyst (Bad Result)-20%
If the Oct 22 EGM vote fails, the cash-gap issue resurfaces unresolved, or the Kenya tender is lost, exit — a failed dated binary is different from ordinary post-run profit-taking
📎 Sources

Generated 2026-09-29 · Not financial advice